Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy

Open access
Zhang, Yu, Chen, Lieping · 2016 · JAMA Oncology

Abstract

The development of inhibitors targeting the programmed cell death 1/B7 homolog 1 (PD-1/B7-H1) (PD) pathway, a mechanism adaptively used by tumors to evade the immune response, has been ground breaking in the treatment of a broad spectrum of advanced cancers, especially solid tumors. Antibody blockade of the PD pathway (anti-PD therapy) repairs this immune deficit in the tumor microenvironment, producing previously unseen durable responses in many patients with advanced-stage cancers, but a large fraction of patients still fail to respond. 1 As clinical responses to anti-PD therapy correlate with the presence of both (B7-H1) expression and immune responses in the tumor, 2 we propose a way of categorizing patients based on Tumor Immunity in the MicroEnvironment (TIME) and discuss its implications in cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaoncol.2016.2450

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 168

Metadata

Authors
Zhang, Y., & Chen, L.
Venue
JAMA Oncology
Published
2016-11-01
Volume
2
Issue
11
Pages
1403
ISSN
2374-2437 (ISSN-L)
OpenAlex
W2488061344
Cited by
168
References
2
FWCI
5.25
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy. https://app.cochat.ai/papers/10.1001/jamaoncol.2016.2450
The paper
Zhang, Y., & Chen, L. (2016). Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2016.2450

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.